AstraZeneca deploys Tibco Spotfire for enterprise analytics


AstraZeneca deploys Tibco Spotfire for enterprise analytics

Antony Savvas

Netherlands-based AstraZeneca is using the Tibco Spotfire enterprise analytics platform to improve sales and marketing efficiency.

The Spotfire business intelligence program delivers real-time performance reporting and analysis to help AstraZeneca's sales and marketing teams improve their efficiency and effectiveness.

Etienne Jap, AstraZeneca director of business report and market resources, said, "We started using Spotfire as a temporary tool to help us manage data in a new SQL data warehouse we had set up to help support sales and marketing analysis.

"Our previous reporting system had relied upon BusinessObjects, but this was not adequate to meet the needs of our expanding sales and marketing teams, as it was slow and we could only get reports on a weekly or monthly basis."

He said, "We found the Tibco Spotfire software so effective that we recommended to our executive team that we expand the use of Spotfire across our entire sales and marketing teams."

Reports are now delivered hourly and daily, and AstraZeneca employees can interrogate the data in different reports and visualisations to see specific performance information relating to different parts of the company.

Currently, around 50 senior managers are using the full Spotfire Enterprise Player, while another 200 AstraZeneca employees, mainly sales reps, will shortly begin using Spotfire with the Tibco Spotfire Web Player for remote access.

>> Business intelligence: An expert view

>> Business intelligence will decline, but still vital

Email Alerts

Register now to receive IT-related news, guides and more, delivered to your inbox.
By submitting your personal information, you agree to receive emails regarding relevant products and special offers from TechTarget and its partners. You also agree that your personal information may be transferred and processed in the United States, and that you have read and agree to the Terms of Use and the Privacy Policy.

COMMENTS powered by Disqus  //  Commenting policy